CAS: 881997-86-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Eptifibatide xAcetate REF: IN-DA01E9MPCAS: 881997-86-0 | 98% | To inquire | Tue 07 Jan 25 |
 | Eptifibatide Acetate REF: 86-MM3543.01CAS: 881997-86-0 | - - - | 1,345.00 € | Tue 07 Jan 25 |
 | Eptifibatide acetate (148031-34-9 free base) REF: TM-T5146CAS: 881997-86-0 | 99.7% - 99.87% | 35.00 €~181.00 € | Mon 13 Jan 25 |
Ref: IN-DA01E9MP
| 1g | To inquire | ||
| 5mg | 119.00 € | ||
| 10mg | 155.00 € | ||
| 50mg | 187.00 € | ||
| 100mg | 162.00 € | ||
| 250mg | 274.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Eptifibatide Acetate
Controlled ProductCAS:881997-86-0
Formula:
C35H49N11O9S2·C2H4O2
Color and Shape:
Neat
Molecular weight:
892.01
Ref: 86-MM3543.01
| 100mg | 1,345.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Eptifibatide acetate (148031-34-9 free base)
CAS:881997-86-0
Eptifibatide acetate (148031-34-9), a cyclic heptapeptide GP IIb/IIIa inhibitor antiplatelet drug.
Formula:
C35H49N11O9S2·xC2H4O2
Purity:
99.7% - 99.87%
Color and Shape:
Solid
Molecular weight:
831.96 (free base)
Ref: TM-T5146
| 5mg | 35.00 € | ||
| 10mg | 39.00 € | ||
| 25mg | 58.00 € | ||
| 50mg | 92.00 € | ||
| 100mg | 130.00 € | ||
| 200mg | 181.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
